Related Experiment Video
Updated: May 7, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Quantum Computing and Quantum Technologies in Drug Discovery and Therapeutics: Evidence, Benchmarking, and
1Department of Pharmaceutical Sciences, University of Illinois, Chicago, IL, 60612, USA.
Quantum technologies offer potential for drug discovery, but validated benchmarks are needed. Near-term value lies in quantum sensing and established physical therapies, while quantum computing requires further development for clinical impact.
Area of Science:
- Quantum technologies and their applications in drug discovery and development.
- Physical therapies and device-led interventions co-evolving with pharmaceutical research.
- Computational chemistry, quantum computing, and machine learning in therapeutic development.
Background:
- Quantum technologies, including computing, sensing, and materials, are proposed to accelerate drug discovery.
- Current claims of "quantum advantage" often lack standardized benchmarks and comparisons to classical methods.
- The review broadens the scope to include device-led therapies alongside quantum approaches.
Purpose of the Study:
- To critically evaluate the current state and future potential of quantum technologies in drug discovery.
- To differentiate and assess quantum computing, quantum sensing, and quantum nanotechnologies.
- To integrate device-based physical therapies into the framework of therapeutic development.
Main Methods:
- Categorization of quantum technologies: computing, sensing, and nanotechnologies.
- Inclusion and analysis of physical therapies: photobiomodulation, focused ultrasound, neuromodulation, and optogenetics.
- Review of near-term quantum computing capabilities (NISQ era), algorithms, and error mitigation.
- Comparison of quantum approaches against classical computational chemistry and machine learning baselines.
Main Results:
- Quantum sensing and established device/physical platforms show the most substantial near-term translational value in drug discovery.
- Quantum computing is currently hypothesis-generating, awaiting fault tolerance and proven advantage.
- Device-based modalities like transcranial photobiomodulation and focused ultrasound are impacting clinical trials and therapeutic landscapes.
Conclusions:
- Validated decision impact, not just quantum novelty, is crucial for drug discovery applications.
- Standardized benchmarks and reproducible results comparable to AI/ML methods are essential for regulated contexts.
- Quantum sensing and physical therapies offer more immediate clinical relevance than quantum computing in the near term.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
08:47Experimental Quantification of Interactions Between Drug Delivery Systems and Cells In Vitro: A Guide for Preclinical Nanomedicine Evaluation
Published on: September 28, 2022
Related Concept Videos
Drug Discovery: Overview
Pharmacogenomics: Identification of New Drug Targets
Quantitative Aspects of Drug-Receptor Interaction
Patch Clamp
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Combination Therapies and Personalized Medicine